. 2024 Aug 20;25(8):294. doi: 10.31083/j.rcm2508294

Table 2.

Baseline characteristics of patients with low (Group 1: GS $<$ 44), medium (Group 2: 44 $\leq$ GS $\leq$ 80) and high (Group 3: GS $>$ 80) Gensini scores.

Variables	Group 1 (n = 146)	Group 2 (n = 218)	Group 3 (n = 178)	p	p_1⁢–⁢2	p_1⁢–⁢3	p_2⁢–⁢3
Age (year)	59.49 $\pm$ 12.74	60.47 $\pm$ 14.55	63.13 $\pm$ 13.47	0.042	0.504	0.018	0.055
Male [n (%)]	122 (83.6%)	170 (78.0%)	143 (80.3%)	0.423
Smoking [n (%)]	85 (58.2%)	117 (53.7%)	99 (55.6%)	0.693
Hypertension [n (%)]	88 (60.3%)	121 (55.5%)	101 (56.7%)	0.659
Diabetes [n (%)]	33 (22.6%)	59 (27.1%)	51 (28.7%)	0.450
SP (mmHg)	125.84 $\pm$ 24.87	126.45 $\pm$ 23.77	129.40 $\pm$ 24.04	0.342
DP (mmHg)	76.45 $\pm$ 15.85	75.72 $\pm$ 15.93	79.54 $\pm$ 15.54	0.047	0.663	0.080	0.017
HR	76.44 $\pm$ 16.46	77.00 $\pm$ 15.47	82.21 $\pm$ 20.13	0.003	0.765	0.003	0.003
Neutrophil ( $\times$ 10⁹/L)	6.13 (4.25, 8.61)	6.98 (5.23, 9.04)	7.90 (5.77, 10.82)	$<$ 0.001	0.023	$<$ 0.001	0.004
Lymphocyte ( $\times$ 10⁹/L)	1.60 (1.18, 2.26)	1.42 (1.00, 2.09)	1.36 (1.05, 1.89)	0.022	0.072	0.028	1.000
Monocyte ( $\times$ 10⁹/L)	0.51 (0.40, 0.70)	0.50 (0.38, 0.70)	0.60 (0.40, 0.80)	0.005	0.566	0.280	0.004
Platelet ( $\times$ 10⁹/L)	196.00 (148.75, 240.00)	197.50 (155.00, 242.00)	189.00 (157.00, 230.75)	0.602
LnPIV	5.32 $\pm$ 0.53	6.50 $\pm$ 0.60	6.41 $\pm$ 1.09	$<$ 0.001	$<$ 0.001	$<$ 0.001	0.242
LnSII	6.23 $\pm$ 0.55	7.06 $\pm$ 0.61	6.99 $\pm$ 0.86	$<$ 0.001	$<$ 0.001	$<$ 0.001	0.315
LnPLR	4.59 $\pm$ 0.44	4.98 $\pm$ 0.49	4.97 $\pm$ 0.55	$<$ 0.001	$<$ 0.001	$<$ 0.001	0.824
LnNLR	1.04 $\pm$ 0.60	1.77 $\pm$ 0.61	1.74 $\pm$ 0.77	$<$ 0.001	$<$ 0.001	$<$ 0.001	0.707
BUN (mmol/L)	5.53 (4.34, 6.83)	5.34 (4.33, 6.55)	5.93 (4.79, 7.36)	$<$ 0.002	1.000	0.032	0.003
Creatinine (μmol/L)	71.10 (60.00, 81.55)	71.00 (58.58, 81.10)	72.40 (60.93, 88.00)	0.381
eGFR (mL/(min $\times$ 1.73 m²))	97.09 (82.80, 103.94)	92.80 (83.55, 106.87)	93.25 (72.59, 105.20)	0.327
UA (mmol/L)	361.46 (294.80, 415.00)	334.50 (287.83, 402.70)	361.46 (295.40, 428.53)	0.065
TP (g/L)	62.35 (59.20, 65.60)	62.70 (59.30, 66.30)	63.13 (60.48, 67.30)	0.097
TG (mmol/L)	1.51 (1.10, 2.23)	1.52 (1.04, 2.20)	1.49 (1.06, 2.10)	0.879
TC (mmol/L)	4.23 (3.55, 4.84)	4.25 (3.66, 5.08)	4.42 (3.88, 5.28)	0.006	1.000	0.008	0.038
LVEF	59.00 (57.00, 64.00)	58.90 (55.00, 63.25)	58.90 (53.75, 62.00)	0.147
LVFS	30.40 (30.00, 33.25)	30.40 (29.00, 33.00)	30.40 (29.00, 33.00)	0.502
Killip Class 2–4 [n (%)]	44 (30.1%)	48 (22.0%)	66 (37.1%)	0.004	0.081	0.189	$<$ 0.001

Continuous variables are expressed as the mean $\pm{}$ SD, and categorical variables are expressed as percentages. The PIV, SII, PLR, and NLR are skewed data, and the natural logarithmic transformation is used for normally distributed data.

SD, standard deviation; GS, Gensini score; LnPIV, natural logarithmic transformation of pan-immune inflammation values; LnSII, natural logarithmic transformation of systemic immune inflammation indices; LnPLR, natural logarithmic transformation of platelet-to-lymphocyte ratios; LnNLR, natural logarithmic transformation of neutrophil-to-lymphocyte ratios; BUN, blood urea nitrogen; eGFR, glomerular filtration rate; UA, uric acid; TP, total protein; TG, triglyceride; TC, cholesterol; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; DP, diastolic blood pressure; SP, systolic blood pressure; HR, heart rate.